My NCBI | Sign In
RSS Settings
  • Search: Sciacqua A[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 25

    1.

    Renal function predicts cardiovascular outcomes in southern Italian postmenopausal women.

    Perticone F, Sciacqua A, Maio R, Perticone M, Laino I, Bruni R, Cello SD, Leone GG, Greco L, Andreozzi F, Sesti G.

    Eur J Cardiovasc Prev Rehabil. 2009 Aug;16(4):481-6.PMID: 19531955 [PubMed - indexed for MEDLINE]Related articles

    2.

    Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis.

    Succurro E, Marini MA, Arturi F, Grembiale A, Lugarà M, Andreozzi F, Sciacqua A, Lauro R, Hribal ML, Perticone F, Sesti G.

    Atherosclerosis. 2009 Nov;207(1):245-9. Epub 2009 Apr 11.PMID: 19410252 [PubMed - in process]Related articles

    3.

    Insulin-like growth factor-1 and glomerular filtration rate in hypertensive patients.

    Perticone F, Maio R, Sciacqua A, Perticone M, Laino I, Miceli S, Mazzaferro D, Pascale A, Andreozzi F, Giorgio Sesti.

    J Hypertens. 2009 Mar;27(3):613-7.PMID: 19330922 [PubMed - indexed for MEDLINE]Related articles

    4.

    Differences in cardiovascular risk profile based on relationship between post-load plasma glucose and fasting plasma levels.

    Succurro E, Marini MA, Grembiale A, Lugarà M, Andreozzi F, Sciacqua A, Hribal ML, Lauro R, Perticone F, Sesti G.

    Diabetes Metab Res Rev. 2009 May;25(4):351-6.PMID: 19319930 [PubMed - indexed for MEDLINE]Related articles

    5.

    Endothelial dysfunction, ADMA and insulin resistance in essential hypertension.

    Perticone F, Sciacqua A, Maio R, Perticone M, Galiano Leone G, Bruni R, Di Cello S, Pascale A, Talarico G, Greco L, Andreozzi F, Sesti G.

    Int J Cardiol. 2009 Jan 23. [Epub ahead of print]PMID: 19168237 [PubMed - as supplied by publisher]Related articles

    6.

    Low-plasma insulin-like growth factor-I levels are associated with impaired endothelium-dependent vasodilatation in a cohort of untreated, hypertensive Caucasian subjects.

    Perticone F, Sciacqua A, Perticone M, Laino I, Miceli S, Care' I, Galiano Leone G, Andreozzi F, Maio R, Sesti G.

    J Clin Endocrinol Metab. 2008 Jul;93(7):2806-10. Epub 2008 Apr 22.PMID: 18430768 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Microalbuminuria, endothelial dysfunction and inflammation in primary hypertension.

    Perticone F, Maio R, Tripepi G, Sciacqua A, Mallamaci F, Zoccali C.

    J Nephrol. 2007 Nov-Dec;20 Suppl 12:S56-62.PMID: 18050145 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Conceptual basis and methodology of the SOPHIA study.

    Glorioso N, Argiolas G, Filigheddu F, Troffa C, Cocco F, Bulla E, Bulla P, Zaninello R, Degortes S, Pitzoi S, Frau F, Fadda S, Pinna Parpaglia P, Bernini G, Bardini M, Fallo F, Malatino L, Regolisti G, Ferri C, Cusi D, Sciacqua A, Perticone F, Degli Esposti E, Baraccani C, Parati G, Veglio F, Mulatero P, Williams TA, Macciardi F, Stancanelli B; Study Group on Cardiovascular Pharmacogenomics of Italian Society of Hypertension.

    Pharmacogenomics. 2007 Nov;8(11):1497-509.PMID: 18034615 [PubMed - indexed for MEDLINE]Related articles

    9.

    Endothelial dysfunction and C-reactive protein are risk factors for diabetes in essential hypertension.

    Perticone F, Maio R, Sciacqua A, Andreozzi F, Iemma G, Perticone M, Zoccali C, Sesti G.

    Diabetes. 2008 Jan;57(1):167-71. Epub 2007 Oct 10.PMID: 17928395 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Gly460Trp alpha-adducin gene polymorphism and endothelial function in untreated hypertensive patients.

    Perticone F, Sciacqua A, Barlassina C, Del Vecchio L, Signorello MC, Dal Fiume C, Andreozzi F, Sesti G, Cusi D.

    J Hypertens. 2007 Nov;25(11):2234-9. Erratum in: J Hypertens. 2008 Feb;26(2):380. PMID: 17921817 [PubMed - indexed for MEDLINE]Related articles

    11.

    Role of PC-1 and ACE genes on insulin resistance and cardiac mass in never-treated hypertensive patients. Suggestive evidence for a digenic additive modulation.

    Perticone F, Maio R, Di Paola R, Sciacqua A, Marucci A, De Cosmo S, Perticone M, Sesti G, Trischitta V.

    Nutr Metab Cardiovasc Dis. 2007 Mar;17(3):181-7. Epub 2006 Mar 20.PMID: 17367703 [PubMed - indexed for MEDLINE]Related articles

    12.

    Metabolic and cardiovascular risk factors in subjects with impaired fasting glucose: the 100 versus 110 mg/dL threshold.

    Andreozzi F, Succurro E, Mancuso MR, Perticone M, Sciacqua A, Perticone F, Sesti G.

    Diabetes Metab Res Rev. 2007 Oct;23(7):547-50.PMID: 17311284 [PubMed - indexed for MEDLINE]Related articles

    13.

    Interleukin-6 impairs the insulin signaling pathway, promoting production of nitric oxide in human umbilical vein endothelial cells.

    Andreozzi F, Laratta E, Procopio C, Hribal ML, Sciacqua A, Perticone M, Miele C, Perticone F, Sesti G.

    Mol Cell Biol. 2007 Mar;27(6):2372-83. Epub 2007 Jan 22.PMID: 17242212 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Effects of growth hormone and insulin-like growth factor-1 on cardiac hypertrophy of hypertensive patients.

    Sesti G, Sciacqua A, Scozzafava A, Vatrano M, Angotti E, Ruberto C, Santillo E, Parlato G, Perticone F.

    J Hypertens. 2007 Feb;25(2):471-7.PMID: 17211256 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effect of interaction between left ventricular dysfunction and endothelial function in hypertension.

    Sciacqua A, Borrello F, Vatrano M, Grembiale RD, Perticone F.

    Curr Hypertens Rep. 2006 Jun;8(3):212-8. Review.PMID: 17147919 [PubMed - indexed for MEDLINE]Related articles

    16.

    Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension.

    Perticone F, Sciacqua A, Maio R, Perticone M, Maas R, Boger RH, Tripepi G, Sesti G, Zoccali C.

    J Am Coll Cardiol. 2005 Aug 2;46(3):518-23.PMID: 16053968 [PubMed - indexed for MEDLINE]Related articles

    17.

    Interaction between vascular dysfunction and cardiac mass increases the risk of cardiovascular outcomes in essential hypertension.

    Sciacqua A, Scozzafava A, Pujia A, Maio R, Borrello F, Andreozzi F, Vatrano M, Cassano S, Perticone M, Sesti G, Perticone F.

    Eur Heart J. 2005 May;26(9):921-7. Epub 2005 Feb 2.PMID: 15689344 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance.

    Sesti G, Sciacqua A, Cardellini M, Marini MA, Maio R, Vatrano M, Succurro E, Lauro R, Federici M, Perticone F.

    Diabetes Care. 2005 Jan;28(1):120-5.PMID: 15616244 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Impaired endothelial function in never-treated hypertensive subjects carrying the Arg972 polymorphism in the insulin receptor substrate-1 gene.

    Perticone F, Sciacqua A, Scozzafava A, Ventura G, Laratta E, Pujia A, Federici M, Lauro R, Sesti G.

    J Clin Endocrinol Metab. 2004 Jul;89(7):3606-9.PMID: 15240653 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    The -866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes.

    D'Adamo M, Perego L, Cardellini M, Marini MA, Frontoni S, Andreozzi F, Sciacqua A, Lauro D, Sbraccia P, Federici M, Paganelli M, Pontiroli AE, Lauro R, Perticone F, Folli F, Sesti G.

    Diabetes. 2004 Jul;53(7):1905-10.PMID: 15220218 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    The Arg972 variant in insulin receptor substrate-1 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes.

    Sesti G, Marini MA, Cardellini M, Sciacqua A, Frontoni S, Andreozzi F, Irace C, Lauro D, Gnasso A, Federici M, Perticone F, Lauro R.

    Diabetes Care. 2004 Jun;27(6):1394-8.PMID: 15161794 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells.

    Andreozzi F, Laratta E, Sciacqua A, Perticone F, Sesti G.

    Circ Res. 2004 May 14;94(9):1211-8. Epub 2004 Mar 25.PMID: 15044323 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Relation of fasting insulin related to insertion/deletion polymorphism of angiotensin-converting enzyme-gene and cardiac mass in never-treated patients with systemic hypertension.

    Ceravolo R, Maio R, Cuda G, Scozzafava A, Sciacqua A, Vatrano M, Bellieni G, D'Angelo G, Schipani FA, Sesti G, Perticone F.

    Am J Cardiol. 2003 Nov 15;92(10):1234-7.PMID: 14609609 [PubMed - indexed for MEDLINE]Related articles

    24.

    Pulse pressure and endothelial dysfunction in never-treated hypertensive patients.

    Ceravolo R, Maio R, Pujia A, Sciacqua A, Ventura G, Costa MC, Sesti G, Perticone F.

    J Am Coll Cardiol. 2003 May 21;41(10):1753-8.PMID: 12767660 [PubMed - indexed for MEDLINE]Related articles

    25.

    Weight loss in combination with physical activity improves endothelial dysfunction in human obesity.

    Sciacqua A, Candigliota M, Ceravolo R, Scozzafava A, Sinopoli F, Corsonello A, Sesti G, Perticone F.

    Diabetes Care. 2003 Jun;26(6):1673-8.PMID: 12766092 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    1 free full-text article in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...